National Institutes of Health Grant Opportunities

Open federal grant opportunities from National Institutes of Health, newest first. 96 listed.

• Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-02-10

• Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-02-18

• Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)

  National Institutes of Health · Due 2028-02-17

• Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

  National Institutes of Health · Due 2028-10-10

• The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-03-05

• The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-03-05

• Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2029-11-16

• George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)

  National Institutes of Health · Due 2027-02-01

• Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-01-08

• Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-01-08

• Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-01-08

• NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2030-12-01

• CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect

  National Institutes of Health · Due 2027-10-01

• Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)

  National Institutes of Health · Due 2027-10-28

• Discovery Gateway to Reproductive Health Innovation

  National Institutes of Health · Due 2027-10-01

• National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-11-01

• Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-03-05

• Immune Tolerance Network (UM1 Clinical Trial Required)

  National Institutes of Health · Due 2027-01-29

• Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-01-29

• Learning Disabilities Research Centers

  National Institutes of Health · Due 2027-10-01

• Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

  National Institutes of Health · Due 2029-07-16

• NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-02-11

• Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2029-05-25

• Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)

  National Institutes of Health · Due 2026-11-17

• Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-02-11

• Specialized Alcohol Research Centers (P50 Clinical trial Optional)

  National Institutes of Health · Due 2027-01-27

• Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

  National Institutes of Health · Due 2029-10-11

• Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

  National Institutes of Health · Due 2029-09-25

• Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2028-01-25

• Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs)

  National Institutes of Health · Due 2027-05-25

• Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-02-11

• Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2028-10-13

• Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-02-08

• Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-02-09

• Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

  National Institutes of Health · Due 2027-09-25

• Centers for Research on Neglected Infectious Diseases

  National Institutes of Health · Due 2027-06-15

• Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-05-28

• HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

  National Institutes of Health · Due 2027-09-07

• Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-10-28

• BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2029-02-08

• Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

  National Institutes of Health · Due 2027-07-31

• HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

  National Institutes of Health · Due 2026-10-30

• Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

  National Institutes of Health · Due 2029-11-05

• Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-05-25

• NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2029-11-16

• Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

  National Institutes of Health · Due 2026-11-10

• LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)

  National Institutes of Health · Due 2027-10-18

• The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

  National Institutes of Health · Due 2027-10-13

• Partnerships for Advancing Development of Diagnostics for Infectious Diseases

  National Institutes of Health · Due 2027-10-14

• Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)

  National Institutes of Health · Due 2027-05-08